Trial · NCT02008422
Clinical Study of Endostar Injection Concomitant With SOX Protocols to Treat Advanced Gastric Cancer
NCT02008422, Phase 3, Unknown, Tang Xushan
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Clinical Study of Endostar Injection Concomitant With SOX Protocols to Treat Advanced Gastric Cancer. Trials, record NCT02008422. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT02008422
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Clinical Study of Endostar Injection Concomitant With SOX Protocols to Treat Advanced Gastric Cancer
- NCT number
- NCT02008422
- Status
- Unknown
- Phases
- Phase 3
- Enrollment
- 120 participants, estimated
- Lead sponsor
- Tang Xushan
- Conditions
- Gastric Cancer
- Interventions
- Oxaliplatin, Gimeracil and Oteracil Potassium Capsule, Endostar injection
- First posted
- 2013-12-11
- Last updated
- 2013-12-11
Source ClinicalTrials.gov
Registered outcomes4
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Response rate (RR) | The patients were followed up for 3 years. | * Clinical RR=(CR＋PR)/total cases×100%; * Complete remission (CR): all visible nidi disappeared; * Partial remission (PR): the decreased total length of diameter of baseline nidus≥30%; |
| Primary | clinical benefit rate (CBR) | The patients were followed up for 3 years. | * Clinical CBR＝(CR＋PR＋SD)/total cases×100% * Complete remission (CR): all visible nidi disappeared; * Stable disease (SD): the total length of diameter of baseline nidus decreased\<that in PR or increased \<that in PD.-Progressive disease (PD): the increased total length of diameter of baseline nidus≥30% or new nidus was presented; |
| Primary | progression-free survival (PFS) | The patients were followed up for 3 years | PFS was from randomization to tumor progression or death. |
| Secondary | overall survival (OS) | The patients were followed up for 3 years |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT02008422
GET https://conductscience.org/api/trials/v1/NCT02008422/registered